288 related articles for article (PubMed ID: 28777224)
1. Short-term Results of Trabeculectomy Using Adjunctive Intracameral Bevacizumab Versus Mitomycin C: A Randomized Controlled Trial.
Vahedian Z; Mafi M; Fakhraie G; Zarei R; Eslami Y; Ghadimi H; Mohebbi M
J Glaucoma; 2017 Sep; 26(9):829-834. PubMed ID: 28777224
[TBL] [Abstract][Full Text] [Related]
2. Short-term Results of Trabeculectomy Using Adjunctive Intracameral Bevacizumab: A Randomized Controlled Trial.
Fakhraie G; Ghadimi H; Eslami Y; Zarei R; Mohammadi M; Vahedian Z; Mafi M; Moghimi S
J Glaucoma; 2016 Mar; 25(3):e182-8. PubMed ID: 25493621
[TBL] [Abstract][Full Text] [Related]
3. Role of subconjunctival bevacizumab as an adjuvant to primary trabeculectomy: a prospective randomized comparative 1-year follow-up study.
Akkan JU; Cilsim S
J Glaucoma; 2015 Jan; 24(1):1-8. PubMed ID: 23661044
[TBL] [Abstract][Full Text] [Related]
4. Subconjunctival bevacizumab versus mitomycin C adjunctive to trabeculectomy.
Nilforushan N; Yadgari M; Kish SK; Nassiri N
Am J Ophthalmol; 2012 Feb; 153(2):352-357.e1. PubMed ID: 21982106
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Adjunctive Subconjunctival Bevacizumab on the Outcomes of Primary Trabeculectomy With Mitomycin C: A Prospective Randomized Placebo-controlled Trial.
Kiddee W; Orapiriyakul L; Kittigoonpaisan K; Tantisarasart T; Wangsupadilok B
J Glaucoma; 2015; 24(8):600-6. PubMed ID: 25393038
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Bevacizumab Compared to Mitomycin C Modulated Trabeculectomy in Primary Open Angle Glaucoma: A One-Year Prospective Randomized Controlled Study.
Kaushik J; Parihar JK; Jain VK; Gupta S; Nath P; Durgapal P; Ram J
Curr Eye Res; 2017 Feb; 42(2):217-224. PubMed ID: 27269279
[TBL] [Abstract][Full Text] [Related]
7. Prospective study comparing mitomycin C or bevacizumab as adjuvant in trabeculectomy revision by needling.
Franco L; Rassi B; Avila MP; Magacho L
Eur J Ophthalmol; 2016; 26(3):221-5. PubMed ID: 26449256
[TBL] [Abstract][Full Text] [Related]
8. Biodegradable collagen matrix implant versus mitomycin-C in trabeculectomy: five-year follow-up.
Cillino S; Casuccio A; Di Pace F; Cagini C; Ferraro LL; Cillino G
BMC Ophthalmol; 2016 Mar; 16():24. PubMed ID: 26946419
[TBL] [Abstract][Full Text] [Related]
9. Evaluation the adjunctive use of combined bevacizumab and mitomycinc to trabeculectomy in management of recurrent pediatric glaucoma.
Mahdy RA; Al-Mosallamy SM; Al-Aswad MA; Bor'i A; El-Haig WM
Eye (Lond); 2016 Jan; 30(1):53-8. PubMed ID: 26427987
[TBL] [Abstract][Full Text] [Related]
10. Two-year outcome of repeat trabeculectomy with mitomycin C in primary open-angle and PEX glaucoma.
Meyer LM; Graf NE; Philipp S; Fischer MT; Haller K; Distelmaier P; Schönfeld CL
Eur J Ophthalmol; 2015; 25(3):185-91. PubMed ID: 25449638
[TBL] [Abstract][Full Text] [Related]
11. Anti-vascular endothelial growth factor for control of wound healing in glaucoma surgery.
Cheng JW; Cheng SW; Wei RL; Lu GC
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD009782. PubMed ID: 26769010
[TBL] [Abstract][Full Text] [Related]
12. Mitomycin C-augmented trabeculectomy: subtenon injection versus soaked sponges: a randomised clinical trial.
Pakravan M; Esfandiari H; Yazdani S; Douzandeh A; Amouhashemi N; Yaseri M; Pakravan P
Br J Ophthalmol; 2017 Sep; 101(9):1275-1280. PubMed ID: 28100482
[TBL] [Abstract][Full Text] [Related]
13. Needle bleb revision with bevacizumab and mitomycin C compared with mitomycin C alone for failing filtration blebs.
Tai TY; Moster MR; Pro MJ; Myers JS; Katz LJ
J Glaucoma; 2015; 24(4):311-5. PubMed ID: 25826644
[TBL] [Abstract][Full Text] [Related]
14. Intracameral bevacizumab role in trabeculectomy: A 1-year prospective randomized controlled study.
Rabina G; Barequet D; Mimouni M; Kurtz S; Shemesh G; Rosenblatt A; Rosenfeld E
Eur J Ophthalmol; 2020 Nov; 30(6):1356-1361. PubMed ID: 31496260
[TBL] [Abstract][Full Text] [Related]
15. Trabeculectomy with mitomycin C alone or coupled with intracamerular bevacizumab? A 2-year comparative study.
José P; Teixeira FJ; Barão R; Sousa DC; Marques RE; Barata ADO; Marques-Neves C; Alves M; Papoila AL; Stalmans I; Silva JP; Abegão Pinto L
Br J Ophthalmol; 2022 Oct; 106(10):1399-1405. PubMed ID: 33931389
[TBL] [Abstract][Full Text] [Related]
16. Deep sclerectomy versus punch trabeculectomy: effect of low-dosage mitomycin C.
Cillino S; Di Pace F; Casuccio A; Lodato G
Ophthalmologica; 2005; 219(5):281-6. PubMed ID: 16123554
[TBL] [Abstract][Full Text] [Related]
17. Long-term Outcomes of Mitomycin-C Trabeculectomy in Exfoliative Glaucoma Versus Primary Open-Angle Glaucoma.
Lim SH; Cha SC
J Glaucoma; 2017 Apr; 26(4):303-310. PubMed ID: 26709498
[TBL] [Abstract][Full Text] [Related]
18. The outcome of initial mitomycin C-augmented trabeculectomy with subconjunctival bevacizumab in the management of secondary glaucoma associated with Fuchs heterochromic iridocyclitis.
Elgin U; Sen E; Ozdemir K; Ozdal P; Berker N
Int Ophthalmol; 2020 Apr; 40(4):795-802. PubMed ID: 31792855
[TBL] [Abstract][Full Text] [Related]
19. Trabeculectomy With Mitomycin-C Versus Trabeculectomy With Amniotic Membrane Transplant: A Medium-term Randomized, Controlled Trial.
Khairy HA; Elsawy MF
J Glaucoma; 2015 Sep; 24(7):556-9. PubMed ID: 24844538
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the long-term efficacy of short-duration 0.1 mg/ml and 0.2 mg/ml MMC in primary trabeculectomy for primary adult glaucoma.
Sihota R; Angmo D; Chandra A; Gupta V; Sharma A; Pandey RM
Graefes Arch Clin Exp Ophthalmol; 2015 Jul; 253(7):1153-9. PubMed ID: 25940554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
